The report, prepared by a group of professional market research analysts, targets audiences such as pharmaceuticals manufacturers, hospitals and clinics, research and academic institutions, contract manufacturers, and contract research organizations. The report begins with an overview of the current scenario of the market for allergy immunotherapy, explains the types of immunotherapies, segments it on the basis of methods of administration, gauges the potential of every important region, and provides insights on the competitive landscape by profiling a number of key players for their business overview, financial overview, and recent strategic decisions.
As per the findings of the report, the demand in the global allergy immunotherapy market will increment at a significant CAGR during the forecast period of 2017 to 2021, owing to a number of factors such as presence of high unmet medical needs in emerging economies as a result of escalating geriatric population, existence of novel molecules in pipeline, upsurge of allergies such as asthma, hypertension, and diabetes due to increase in environmental pollution and restless lifestyle of urban populations, and increasing prevalence of allergy rhinitis and asthma along with high consumption of tobacco.
Click to get sample PDF with TOC: https://www.researchmoz.us/enquiry.php?type=S&repid=1345393
The report has detected that technological advancements in the methods of treatment is now gaining awareness not only in the developed countries but also in developing regions. Allergy immunotherapy treatments are gaining adoption among medical professionals.
On the other hand, increasing preference of cell adhesion molecules (CAM), high dropout rates owing to poor patient adherence, and high cost of allergic immunotherapy are some of the challenges that the market must overcome in order to attain its true potential. Nevertheless, the vendors operating in the global allergy immunotherapy market are expected to gain new opportunities from the emergence of SLITT, growing promising of SPIRE, strategic alliances for novel drug developments, and identification of new allergen targets.
It must be noted that allergies are not disease, but merely an over-reaction of body to the foreign substance that is not quite harmful for everyone. For the diagnose an allergy, which are often seasonal and perennial in nature, blood test, skin test, and allergy component tests are undertaken. Also known as allergy shots, allergen immunotherapy is basically a form of extended treatment that reduces symptoms for many people with allergic asthma, allergic rhinitis, stinging insect allergy or conjunctivitis (eye allergy). Immunotherapy involves exposing people to larger and larger amounts of allergen in an affect to change the immune system’s response.
Based on method of administration, this report segments the global allergy immunotherapy market into sublingual (SLIT-tablets/drops), subcutaneous (SCIT), and whole allergen. Geographically, the report has primarily focused on the U.S. allergy immunotherapy market, besides gauging the potential of European market and the rest of the world. For each of the region and country, the report provides market by value, method of administration, common allergies, and regional distribution.
Enquiry: https://www.researchmoz.us/enquiry.php?type=E&repid=1345181
The report has detected a highly competitive scenario in the current market for allergy immunotherapy, wherein companies are dedicated towards manufacturing high safety and efficacy drugs. The report profiles Merck Group, ALK-Abello, Allergy Therapeutics plc, and Stallergenes in order to represent the strategies of the key companies of this market. Mitsubishi Tanabe Pharma, Aimmune Therapeutics, Adamis Pharmaceuticals, ASIT biotech, Biomay, Anergis, Circassia, Genentech, HAL Allergy, DBV Technologies, Laboratorios LETI, Nycomed, Sementis, Shionogi, Torii, Tunitas Therapeutics, Verona Pharma, and VentiRx Pharmaceuticals are some of the other prominent vendors eyeing a position a strength in the global allergy immunotherapy market.
Browse more details at: https://www.researchmoz.us/global-allergy-immunotherapy-market-2017-2021-edition-report.html
About Us
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Media Contact
Company Name: Researchmoz Global Pvt. Ltd.
Contact Person: Rohit Bhisey
Email: sales@researchmoz.us
Phone: +15186212074
Address:90 State Street
City: Albany
State: New York 12207
Country: United States
Website: https://www.researchmoz.us/